Evidence map›Paper›PMID 37719842›Full record

ArticleFrontiers in pharmacology2023

Feasibility of combination of Gun-Chil-Jung and cytokine-induced killer cells-based immunotherapy for terminal hepatocellular carcinoma patient: a case report.

Chan-Ran Park, Hye-Ri Bae, Ga-Young Lee, Chang-Gue Son, Jung-Hyo Cho, Chong-Kwan Cho, Nam-Hun Lee

Abstract readCase Reports
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chan-Ran ParkDepartment of Hepatology and Hematology, Graduated School of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.
Hye-Ri BaeDepartment of Hepatology and Hematology, Graduated School of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.
Ga-Young LeeDepartment of Hepatology and Hematology, Graduated School of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.
Chang-Gue SonDepartment of Hepatology and Hematology, Graduated School of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.
Jung-Hyo ChoDepartment of Hepatology and Hematology, Graduated School of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.
Chong-Kwan ChoDepartment of Hepatology and Hematology, Graduated School of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.
Nam-Hun LeeDepartment of Hepatology and Hematology, Graduated School of Korean Medicine, Daejeon University, Daejeon, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

case reportcytokine-induced killer cell-based immunotherapyGun-Chil-Junghepatocellular carcinomaoncology

Identifiers

PMID37719842
PMCPMC10502300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.